This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age | MicrobiomeTrials
← Back to trials NCT05630859
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age Completed PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2022-11-28Est. Completion: 2025-05-22
Enrollment target: 1,009 participantsLocations GSK Investigational Site, Washington D.C., District of Columbia, United States GSK Investigational Site, Lenexa, Kansas, United States GSK Investigational Site, Boston, Massachusetts, United States GSK Investigational Site, Springfield, Missouri, United States GSK Investigational Site, The Bronx, New York, United States GSK Investigational Site, Pittsburgh, Pennsylvania, United States GSK Investigational Site, Austin, Texas, United States GSK Investigational Site, Salvador, Brazil GSK Investigational Site, Lyon, France GSK Investigational Site, Paris, France GSK Investigational Site, Pierre-Bénite, France GSK Investigational Site, Bochum, Germany GSK Investigational Site, Frankfurt, Germany GSK Investigational Site, Hamburg, Germany GSK Investigational Site, Manila, Philippines GSK Investigational Site, Johannesburg, South Africa GSK Investigational Site, Soweto, South Africa GSK Investigational Site, Barcelona, Spain Other microbiome trials you might be interested in Hepatitis C Hepatitis B
This study will evaluate hepatitis C virus (HCV) infection in blood donors who test positive for antibodies to this viru…
Bethesda, United States
HIV Infections
This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) …
Multiple Locations Est. completion Sep 4, 2029
GSK Investigational Site, Madrid, Spain
GSK Investigational Site, Madrid, Spain
GSK Investigational Site, Valencia, Spain
GSK Investigational Site, London, United Kingdom
GSK Investigational Site, London, United Kingdom